{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:46Z","timestamp":1792784266568,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"FIS","award":["10\/01748"],"award-info":[{"award-number":["10\/01748"]}]},{"name":"Tu eliges, Tu decides\u201d"},{"name":"Spanish Ministerio de Ciencia y Tecnolog\u00eda","award":["SAF2010\u201318472"],"award-info":[{"award-number":["SAF2010\u201318472"]}]},{"name":"Spanish Ministerio de Ciencia y Tecnolog\u00eda","award":["SAF2008\u201303229-E"],"award-info":[{"award-number":["SAF2008\u201303229-E"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neurobiolaging.2012.06.005","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T15:02:36Z","timestamp":1341241356000},"page":"805-808","source":"Crossref","is-referenced-by-count":194,"title":["CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients"],"prefix":"10.1016","volume":"34","author":[{"given":"Maite","family":"Solas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib1","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib2","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials [erratum in 2008;371:558]","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.biopsych.2010.09.020","article-title":"What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease?","volume":"68","author":"Cummings","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","article-title":"Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease","volume":"27","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2007-12402","article-title":"Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease","volume":"12","author":"Gr\u00fcnblatt","year":"2007","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S0033291700032888","article-title":"The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities","volume":"22","author":"Hope","year":"1992","journal-title":"Psychol. Med"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.57.5.805","article-title":"Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex","volume":"57","author":"Lai","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuint.2010.10.010","article-title":"Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex","volume":"57","author":"Lee","year":"2010","journal-title":"Neurochem. Int"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(01)00393-1","article-title":"The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders","volume":"26","author":"Lewis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-2008-14104","article-title":"Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease","volume":"14","author":"Marcos","year":"2008","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib13","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neurobiolaging.2012.06.005_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"1283","author":"Tol\u00f3n","year":"2009","journal-title":"Brain Res"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801200334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:23:09Z","timestamp":1561886589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801200334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S019745801200334X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.06.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}